Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod

被引:3
|
作者
Morillos, Matheus Bernardon [1 ]
Pires de Aguiar, Paulo Henrique [2 ]
Franceschini, Paulo Roberto [3 ]
Duarte, Juliana Avila [4 ]
Piccini, Cristian Daniel [5 ]
Finkelsztejn, Alessandro [1 ]
机构
[1] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Sao Paulo, Dept Neurol, Sao Paulo, Brazil
[3] Hosp Saude, Dept Neurosurg, Caxias Do Sul, RS, Brazil
[4] Hosp Clin Porto Alegre, Dept Internal Med, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul, Fac Med, Rua Ramiro Barcelos 2400, BR-90035002 Porto Alegre, RS, Brazil
关键词
Lymphoma; Fingolimod; Multiple sclerosis; CNS; Primary; Brain; CELL LYMPHOMA;
D O I
10.1007/s10072-022-06367-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Primary central nervous system lymphoma (PCNSL) is an uncommon lymphoproliferative disease associated with immunosuppression. Here, we report the case of a patient with multiple sclerosis, under treatment with fingolimod (FTY720, Gilenya) for 4 years, who developed this condition. Although the causal relationship cannot be established, there are cases in the literature that describe the appearance of lymphoma after the use of this medication. Considering the high mortality of PCNSL, epidemiological studies are necessary to establish a relationship between its arising and the use of immunosuppressants.
引用
收藏
页码:361 / 363
页数:3
相关论文
共 50 条
  • [1] Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod
    Matheus Bernardon Morillos
    Paulo Henrique Pires de Aguiar
    Paulo Roberto Franceschini
    Juliana Ávila Duarte
    Cristian Daniel Piccini
    Alessandro Finkelsztejn
    Neurological Sciences, 2023, 44 : 361 - 363
  • [2] A Case of Primary Central Nervous System Lymphoma That Developed in a Patient Receiving Fingolimod Therapy for Multiple Sclerosis
    Takanashi, Kengo
    Fukami, Shinjiro
    Akimoto, Jiro
    Matsubayashi, Jun
    Kohno, Michihiro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [3] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA IMITATES MULTIPLE-SCLEROSIS
    DEANGELIS, LM
    JOURNAL OF NEURO-ONCOLOGY, 1990, 9 (02) : 177 - 181
  • [4] The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
    Samuel F. Hunter
    James D. Bowen
    Anthony T. Reder
    CNS Drugs, 2016, 30 : 135 - 147
  • [5] Hypothalamic dysfunction in a patient with primary lymphoma of the central nervous system
    Darko Antic
    Mihajlo Smiljanic
    Jelena Bila
    Snezana Jankovic
    Milena Todorovic
    Bosko Andjelic
    Biljana Mihaljevic
    Neurological Sciences, 2012, 33 : 387 - 390
  • [6] Hypothalamic dysfunction in a patient with primary lymphoma of the central nervous system
    Antic, Darko
    Smiljanic, Mihajlo
    Bila, Jelena
    Jankovic, Snezana
    Todorovic, Milena
    Andjelic, Bosko
    Mihaljevic, Biljana
    NEUROLOGICAL SCIENCES, 2012, 33 (02) : 387 - 390
  • [7] Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosis
    Chacko, Joseph A.
    Strati, Paolo
    Stout, Paul W.
    Archer, Robert L.
    Baltz, Brad P.
    Chacko, Joseph G.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [8] Fingolimod-induced bladder lymphoma in a patient with multiple sclerosis
    Vaheb, Saeed
    Ghaffary, Elham Moases
    Shaygannejad, Vahid
    Mirmosayyeb, Omid
    CLINICAL CASE REPORTS, 2023, 11 (04):
  • [9] The Development of Primary Central Nervous System B-Cell Lymphoma in Multiple Sclerosis
    Lyons, Mark K.
    Boucher, Orland K.
    Birch, Barry D.
    Patel, Naresh P.
    NEUROHOSPITALIST, 2011, 1 (03) : 133 - 136
  • [10] Primary Central Nervous System Lymphoma in a Patient Treated With Natalizumab
    Schweikert, Andreas
    Kremer, Marcus
    Ringel, Florian
    Liebig, Thomas
    Duyster, Justus
    Stueve, Olaf
    Hemmer, Bernhard
    Berthele, Achim
    ANNALS OF NEUROLOGY, 2009, 66 (03) : 403 - 406